Early intraarticular injection of HA attenuates the progression of cartilage destruction in the ACLT knee, and the downregulation of the cystine/glutamate antiporter system [Formula: see text] was accompanied by the progression of OA.
We had previously demonstrated that excitatory amino acid glutamate plays a role in the progression and severity of knee osteoarthritis (OA), and early hyaluronic acid injection attenuates the OA progression by attenuation of knee joint glutamate level, which was also related to the cystine/glutamate antiporter system X (system X À C ) expression. System X À C uptakes cystine into chondrocytes for glutathione (GSH) synthesis, but the role of system X À C in OA is rarely addressed. Sulfasalazine (SSZ) is a system X À C inhibitor; SSZ was applied intra-articularly to study the function of system X À C in the development of OA in rats subjected to anterior cruciate ligament transection and medial meniscectomy (ACLT þ MMx). Moerover, the system X À C activator N-acetylcysteine (NAC) was also applied to verify the role of system X À C . The intra-articular injection of SSZ significantly attenuated knee swelling and cartilage destruction in the knees of ACLT þ MMx rats and this effect was blocked by NAC. The results showed that inhibition of system X À C function can attenuate ACLT þ MMx-induced cartilage destruction. In the present study, system X À C inhibitor SSZ was shown to reduce glutamate content in synovial fluid and GSH in chondrocytes. It was also showed SSZ could attenuate ACLT þ MMx-induced cartilage destruction, and treatment of NAC reversed the protective effect of SSZ. ß
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.